亚太药业控制权变更事项相关受让方股权结构调整

Core Viewpoint - Asia-Pacific Pharmaceutical (002370) announced a significant change in its shareholding structure, with a transfer of 14.61% of its shares from its current controlling shareholder, Fubon Group, to Xinghao Holdings, which will result in a new actual controller [1] Group 1: Share Transfer Details - On October 13, Fubon Group and its action-in-concert party, Hangu Investment, signed a share transfer agreement with Xinghao Holdings and Xingchen Investment [1] - The share transfer involves 14.61% of the company's shares at a price of 8.26 yuan per share, totaling 900 million yuan [1] - Following the completion of this transfer, the controlling shareholder will change from Fubon Group to Xinghao Holdings, and the actual control will shift from the management team led by Song Hanping, Fu Cai, and Hu Zhenghui to Qiu Zhongxun [1] Group 2: Investment Structure Adjustment - The announcement also mentioned an adjustment in the investment structure of one of the transferees, Xingchen Investment, which has changed its original limited partner from Anji Jiuheng Venture Capital Co., Ltd. and Anji Shuzhi New Economy Equity Investment Partnership (Limited Partnership) to only Anji Jiuheng Venture Capital Co., Ltd. [1] - Both Anji Jiuheng Venture Capital and Anji Shuzhi New Economy are subsidiaries of the Anji County Finance Bureau [1]